Development of a computational fluid dynamics model for mucociliary clearance in the nasal cavity.

Intranasal drug delivery has attracted significant attention because of the opportunity to deliver systemic drugs directly to the blood stream. However, the mucociliary clearance poses a challenge in gaining high efficacy of intranasal drug delivery because cilia continuously carry the mucus blanket towards the laryngeal region. To better understand mucus flow behaviour on the human nasal cavity wall, we present computational model development, and evaluation of mucus motion on a realistic nasal cavity model reconstructed from CT-scans. The model development involved two approaches based on the actual nasal cavity geometry namely: (i) unwrapped-surface model in 2D domain and (ii) 3D-shell model. Conservation equations of fluid motion were applied to the domains, where a mucus production source term was used to initiate the mucus motion. The analysis included mucus flow patterns, virtual saccharin tests and quantitative velocity magnitude analysis, which demonstrated that the 3D-shell model results provided better agreement with experimental data. The unwrapped-surface model also suffered from mesh-deformations during the unwrapping stage and this led to higher mucus velocity compared to experimental data. Therefore, the 3D-shell model was recommended for future mucus flow simulations. As a first step towards mucus motion modelling this study provides important information that accurately simulates a mucus velocity field on a human nasal cavity wall, for assessment of toxicology and efficacy of intranasal drug delivery.

[1]  Dahl,et al.  Anatomy, physiology and function of the nasal cavities in health and disease. , 1998, Advanced drug delivery reviews.

[2]  Kiao Inthavong,et al.  Effects of nasal drug delivery device and its orientation on sprayed particle deposition in a realistic human nasal cavity , 2016, Comput. Biol. Medicine.

[3]  A ShahSamir,et al.  Design of experiments to optimize an in vitro cast to predict human nasal drug deposition. , 2014 .

[4]  H. Wagner,et al.  Measurement of mucociliary function in man. , 1969, The American review of respiratory disease.

[5]  Jiyuan Tu,et al.  Comparative numerical modeling of inhaled micron-sized particle deposition in human and rat nasal cavities , 2015, Inhalation toxicology.

[6]  J. Blake,et al.  MECHANICS OF CILIARY LOCOMOTION , 1974, Biological reviews of the Cambridge Philosophical Society.

[7]  S. Decreton,et al.  Density of epithelial cells in the normal human nose and the paranasal sinus mucosa. A scanning electron microscopic study. , 1990, Rhinology.

[8]  Jiyuan Tu,et al.  Surface mapping for visualization of wall stresses during inhalation in a human nasal cavity , 2014, Respiratory Physiology & Neurobiology.

[9]  S. Randell,et al.  Coordinated clearance of periciliary liquid and mucus from airway surfaces. , 1998, The Journal of clinical investigation.

[10]  J. Zahm,et al.  Rheological properties controlling mucociliary frequency and respiratory mucus transport. , 1987, Biorheology.

[11]  I. Andersen,et al.  Human Nasal Mucosal , 1971 .

[12]  M. King,et al.  A planar model for mucociliary transport: effect of mucus viscoelasticity. , 1993, Biorheology.

[13]  P. Satir,et al.  The physiology of cilia and mucociliary interactions. , 1990, Annual review of physiology.

[14]  N. Jones,et al.  The rheology of nasal mucus: a review. , 1998, Clinical otolaryngology and allied sciences.

[15]  J. Tu,et al.  Effect of morphology on nanoparticle transport and deposition in human upper tracheobronchial airways , 2018 .

[16]  Pedro Plaza Valía,et al.  [Saccharin test for the study of mucociliary clearance: reference values for a Spanish population]. , 2008 .

[17]  J. Mestecky Historical Aspects of Mucosal Immunology , 2005 .

[18]  P. Verdugo Goblet cells secretion and mucogenesis. , 1990, Annual review of physiology.

[19]  J. Tu,et al.  Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery , 2017, Pharmaceutical Research.

[20]  M. Hindle,et al.  Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties , 2015, Pharmaceutical Research.

[21]  L. Illum Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[22]  S. Gizurarson The effect of cilia and the mucociliary clearance on successful drug delivery. , 2015, Biological & pharmaceutical bulletin.

[23]  Jiyuan Tu,et al.  Computational fluid dynamics analysis of wall shear stresses between human and rat nasal cavities , 2017 .

[24]  F. Baroody Nasal and paranasal sinus anatomy and physiology. , 2007, Clinical allergy and immunology.

[25]  Lisbeth Illum,et al.  Nanoparticles for direct nose-to-brain delivery of drugs. , 2009, International journal of pharmaceutics.

[26]  P. Longest,et al.  Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Development of a CFD Model. , 2016, Journal of aerosol medicine and pulmonary drug delivery.

[27]  G. Fulford,et al.  Muco-ciliary transport in the lung. , 1986, Journal of theoretical biology.

[28]  R. Davies,et al.  The assessment of nasal mucociliary clearance and the effect of drugs. , 1994, Respiratory medicine.

[29]  A. Falcão,et al.  Intranasal drug delivery: how, why and what for? , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[30]  Kiao Inthavong,et al.  Local deposition fractions of ultrafine particles in a human nasal-sinus cavity CFD model , 2012, Inhalation toxicology.

[31]  Schipper,et al.  Nasal mucociliary clearance as a factor in nasal drug delivery. , 1998, Advanced drug delivery reviews.

[32]  R. Chen,et al.  From the Cover: Comparative Numerical Modeling of Inhaled Nanoparticle Deposition in Human and Rat Nasal Cavities. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  F. Merkus,et al.  The Nasal Mucociliary Clearance: Relevance to Nasal Drug Delivery , 1991, Pharmaceutical Research.

[34]  R. Kinget,et al.  Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. , 2005, Advanced drug delivery reviews.

[35]  K. Kovitz,et al.  A roentgenographic method for measuring nasal mucous velocity. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[36]  N. Jones,et al.  Mucociliary transport and its assessment: a review. , 1998, Clinical otolaryngology and allied sciences.

[37]  P. P. Valía,et al.  Test de la sacarina en el estudio del aclaramiento mucociliar. Valores de referencia en una población española , 2008 .

[38]  Jiyuan Tu,et al.  Partitioning of dispersed nanoparticles in a realistic nasal passage for targeted drug delivery , 2018, International journal of pharmaceutics.

[39]  A. Foresi,et al.  Measurement of nasal mucociliary clearance. , 1989, Archives of disease in childhood.